TimeMon-Sat 9.00 AM - 6.00 PM
PLERIXAFOR INJECTION

PLERIXAFOR INJECTION

Product Details:

  • Dosage Form Injection
  • Salt Composition Plerixafor 24 mg/1.2 ml (20 mg/ml)
  • Indication Used to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with Non-Hodgkins Lymphoma and Multiple Myeloma.
  • Feature Sterile, single-use vial
  • Ingredients Plerixafor (active ingredient), excipients for injection
  • Application Hematopoietic Stem Cell Mobilization
  • Physical Color/Texture Clear, colorless to pale yellow solution
  • Click to view more
X

PLERIXAFOR INJECTION Price And Quantity

  • 10000 Unit

PLERIXAFOR INJECTION Product Specifications

  • Plerixafor 24 mg/1.2 ml (20 mg/ml)
  • Hematopoietic Stem Cell Mobilization
  • Plerixafor (active ingredient), excipients for injection
  • AS PER INSTRUCTIONS
  • 24 months
  • Used to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with Non-Hodgkins Lymphoma and Multiple Myeloma.
  • Sterile, single-use vial
  • Injection
  • Clear, colorless to pale yellow solution
  • Prescription Only
  • L03AX16
  • 24 mg/1.2 ml per vial
  • Subcutaneous injection
  • 1 vial per box
  • Ready-to-use solution

PLERIXAFOR INJECTION Trade Information

  • AHEMDABAD, MUNDRA & MUMBAI
  • 10000 Unit Per Month
  • 4 Week
  • Yes
  • Free samples available with shipping and taxes paid by the buyer
  • AS PER REQUIREMENT
  • Western Europe, Australia, North America, Eastern Europe, Middle East, Africa, Central America, South America, Asia
  • All India
  • WHO-GMP

Product Description

ï ïPRODUCT NAME: PLERIXAFOR INJECTION 24MG/1.2ML (20MG/ML)

ï ïGENERIC NAME: PLERIXAFOR INJECTION 24MG/1.2ML (20MG/ML)

ïïïMANUFACTURER: OCEAN

ï ïPACKING: FOR SINGLE VIAL, FOR SUBCUTANEOUS INJECTION ONLY

ïïï USES: Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. Stem cells, which are found mainly in the bone marrow, turn into red blood cells, white blood cells, and platelets. Plerixafor is used to help stem cells move from the bone marrow to the bloodstream so that the cells can be collected and stored. The stem cells are then infused back into the patient after chemotherapy or radiation.




How PLERIXAFOR INJECTION Works

Plerixafor is an active agent that stimulates the movement of hematopoietic stem cells from the bone marrow into the peripheral blood. In patients with certain cancers, mobilizing these cells enhances their collection for autologous transplantation, improving the effectiveness of treatment procedures.


Ready-to-use for Seamless Administration

This injection comes as a clear, sterile, ready-to-use solution in a single-use vial for subcutaneous administration. Healthcare professionals can directly administer the dose, minimizing preparation steps while ensuring safety and sterility.


Storage and Shelf Life

PLERIXAFOR INJECTION should be stored according to manufacturer's instructions to maintain its efficacy. The sterile vials have a shelf life of 24 months, offering convenience for clinics and hospitals managing stem cell mobilization therapies.

FAQ's of PLERIXAFOR INJECTION:


Q: How is PLERIXAFOR INJECTION administered to patients?

A: PLERIXAFOR INJECTION is administered by a healthcare professional through a subcutaneous injection, typically in the abdomen, arm, or thigh. The solution is ready-to-use and requires no dilution or further preparation prior to use.

Q: What is the main purpose of using PLERIXAFOR INJECTION?

A: The primary use of PLERIXAFOR INJECTION is to mobilize hematopoietic stem cells from the bone marrow into the peripheral blood. This allows for easier collection of these cells in patients with Non-Hodgkin's Lymphoma and Multiple Myeloma who are undergoing autologous transplantation.

Q: When should PLERIXAFOR INJECTION be administered during the treatment process?

A: PLERIXAFOR INJECTION is typically given in combination with a growth factor (like G-CSF) a few days prior to stem cell collection. The exact timing and duration are determined by the prescribing physician based on the patient's treatment protocol.

Q: Where should PLERIXAFOR INJECTION be stored for maximum stability?

A: This injection should be stored as per the manufacturer's instructions, usually in a controlled environment specified on the packaging, to maintain its 24-month shelf life and ensure its sterile condition is preserved.

Q: What are the benefits of using PLERIXAFOR INJECTION for stem cell mobilization?

A: Using PLERIXAFOR INJECTION significantly increases the number of stem cells available in the peripheral blood, improving the likelihood of collecting enough cells for a successful autologous transplant and potentially reducing the number of apheresis sessions needed.

Q: Is this injection suitable for use at home or only in a clinical setting?

A: PLERIXAFOR INJECTION must be administered in a medical facility by qualified healthcare professionals. It is a prescription-only medication and should not be used or handled by patients at home.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'ANTI CANCER MEDICINES' category



Back to top